Metraipolis › archive › dc_f302d9dcdbfa

Five-Year Persistence of Vedolizumab in Crohn's Disease: Results from a Real-World Cohort — Europe PMC PMID:41753075

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41753075
DOI: 10.3390/jcm15041387
License (as archived): solo-consultazione
Archived: 2026-11-05T23:44:28.587Z
SHA-256 of the archived text: 9d4cbac0664090988423bf125c8fcb9320ad77b14a3935c442f6300cbbbb74da
Stable URL of this page: https://metraipolis.com/documento/dc_f302d9dcdbfa

How to cite

Five-Year Persistence of Vedolizumab in Crohn's Disease: Results from a Real-World Cohort — Europe PMC PMID:41753075 — Europe PMC (en), https://europepmc.org/article/MED/41753075 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f302d9dcdbfa (Metraipolis archive dc_f302d9dcdbfa, sha256 9d4cbac0664090988423bf125c8fcb9320ad77b14a3935c442f6300cbbbb74da)

BibTeX

@misc{dcf302d9dcdbfa,
  title = {Five-Year Persistence of Vedolizumab in Crohn's Disease: Results from a Real-World Cohort — Europe PMC PMID:41753075},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41753075},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f302d9dcdbfa; sha256 9d4cbac0664090988423bf125c8fcb9320ad77b14a3935c442f6300cbbbb74da},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41753075. Agents can read the archived copy with the MCP tool read_document.